News and Events for Attorneys and Executives

Health Care

image_pdfimage_print

Trial Lawyer Jay Old Joins Texas-based Hicks Thomas LLP

Trial Lawyer Jay Old Joins Texas-based Hicks Thomas LLP

News
Veteran trial lawyer Jay Old has joined commercial litigation firm Hicks Thomas LLP where he will continue to represent construction, insurance, petrochemical and health care companies as part of his client portfolio.

Continue Reading »

Obamacare Replacement May Look Like Existing Law, Without Mandate

Insight
The changes likely will be phased in over time, with very few, if any, immediately repealed. That will allow the new Congress time to fashion replacement parts. And those replacement parts will mostly resemble the old law, says Dallas health care lawyer Jeff Drummond of Jackson Walker LLP.

Continue Reading »

Judge Halves Jury’s $1 Billion Punitive Damages Award in J&J Hip Implant Case

News
U.S. District Judge Ed Kinkeade in Dallas found the jury’s punitive-damage awards to six patients were excessive and should be reduced, according to court filings.

Continue Reading »

If Republicans Repeal Health Law, Paying For A Replacement Could Be Tough

If Republicans Repeal Health Law, Paying For A Replacement Could Be Tough

News
Leading Republicans in Congress have vowed that even if they repeal most of the Affordable Care Act early in 2017, a replacement won’t hurt those now receiving benefits, reports NPR.

Continue Reading »

Nation’s Largest Freestanding ER operator Shedding Executives

News
Graham Cherrington is the second executive to leave the embattled company suddenly in recent months, following a disappointing $11.7 million loss in third quarter.

Continue Reading »

Johnson & Johnson Hit With Over $1 Billion Verdict on Hip Implants

Johnson & Johnson Hit With Over $1 Billion Verdict on Hip Implants

News
The New Jersey pharmaceutical and medical device maker and its DePuy Orthopaedics subsidiary must pay damages to six California plaintiffs who say they suffered serious chronic and painful medical problems caused by the device, reports The Dallas Morning News.

Continue Reading »

U.S. Charges in Generic-Drug Probe to Be Filed by Year-End

U.S. Charges in Generic-Drug Probe to Be Filed by Year-End

News
The antitrust investigation by the Justice Department spans more than a dozen companies and about two dozen drugs, reports Bloomberg.

Continue Reading »

Compliance and Ethics Program Comparison: Survey Results

Compliance and Ethics Program Comparison: Survey Results

Insight
The Society of Corporate Compliance and Ethics and the Health Care Compliance Association recently conducted a survey to gauge the effectiveness of compliance programs at preventing incidents from occurring.

Continue Reading »

Hedge Fund Sues Theranos, Citing ‘Lies, Material Misstatements, and Omissions’

Hedge Fund Sues Theranos, Citing ‘Lies, Material Misstatements, and Omissions’

News
Partner Fund Management, a San Francisco-based hedge fund that reportedly wrote out a $96 million check to Theranos in 2014, is now suing the blood-testing startup and its founder, Elizabeth Holmes, reports TechCrunch.

Continue Reading »

Mylan to Pay $465 Million Over EpiPen Medicaid Rebate Dispute

Mylan to Pay $465 Million Over EpiPen Medicaid Rebate Dispute

News
At issue is whether Mylan made more money on EpiPen than warranted from state Medicaid programs by having it classified as a generic product, Reuters is reporting.

Continue Reading »

Alabama Law Firm Says It Has Received 26k Calls After Talcum Powder Verdicts

Alabama Law Firm Says It Has Received 26k Calls After Talcum Powder Verdicts

News
A law firm in Montgomery, Ala., says it received nearly 26,000 phone calls from people inquiring about a possible link between talcum powder and ovarian cancer after its clients won a total of $127 million in two verdicts earlier this year, reports AL.com.

Continue Reading »

Theranos Walks Away From Zika Test

Theranos Walks Away From Zika Test

News
The move is another setback for the Palo Alto, Calif., company as it tries to recover from crippling regulatory sanctions that followed revelations by The Wall Street Journal of shortcomings in Theranos’s technology and operations.

Continue Reading »

First State-to-State Spread of Zika Magnifies Questions of Employer Liability

First State-to-State Spread of Zika Magnifies Questions of Employer Liability

Insight
While Zika’s dangers first appeared in Brazil, its spread to the U.S. has magnified questions about risk, including to workers whose employers want them to travel, says Justin Markel of Roberts Markel Weinberg Butler Hailey PC.

Continue Reading »

Kentucky AG Sues Johnson & Johnson Over Transvaginal Mesh Marketing

News
CNN is reporting that Kentucky’s attorney general is suing health-care giant Johnson & Johnson for millions of dollars, saying the company “concealed and misrepresented” the risk of its transvaginal mesh products to doctors and patients.

Continue Reading »

Gilead to Get Attorney Fees in Hepatitis C Patent Fight With Merck

Gilead to Get Attorney Fees in Hepatitis C Patent Fight With Merck

News
Gilead Sciences Inc. is entitled to receive the attorney fees it incurred related to hepatitis C patent litigation with drugmaker Merck & Co Inc., a U.S. district judge has ruled, reports Reuters.

Continue Reading »

Largest HIPAA Settlement Ever: What You Need to Know

Insight
The operator of 12 hospitals and more than 200 other treatment centers in Chicago and central Illinois has agreed to the largest settlement to date with the Office for Civil Rights for multiple potential violations of the Health Insurance Portability and Accountability Act, reports Shumaker, Loop & Kendrick.

Continue Reading »

Disruptor Meets Regulator, and Regulator Wins: Lessons Learned from Theranos

Insight
Even in an environment that encourages innovation, health care organizations must understand the scope of regulatory oversight at the federal and state levels, and the range of remedies available to regulators for noncompliance, writes writes Robert E. Wanerman of Epstein Becker & Green.

Continue Reading »

Ex-Johnson & Johnson Unit Execs Guilty of Misdemeanors, Avoid Felony Convictions

News
The jury acquitted the two defendants on felony charges of wire fraud and conspiracy, finding they did not act with intent to defraud or mislead. But the two former executives were convicted on charges of promoting a product for an unapproved use, Reuters reports.

Continue Reading »

U.S. Sues to Block Anthem-Cigna and Aetna-Humana Mergers

U.S. Sues to Block Anthem-Cigna and Aetna-Humana Mergers

News
U.S. Attorney General Loretta E. Lynch said the proposed mergers “would leave much of the multitrillion-dollar health insurance industry in the hands of three mammoth insurance companies,” reports The New York Times.

Continue Reading »

Theranos CEO Holmes Banned From Operating a Lab for 2 Years

Theranos CEO Holmes Banned From Operating a Lab for 2 Years

News
Theranos Inc.’s Chief Executive Officer Elizabeth Holmes was banned for two years from owning or operating laboratories by U.S. regulators, a major blow against the controversial blood-testing startup that’s come under scrutiny for risking patient harm with unreliable tests, reports Doni Bloomfield for Bloomberg Technology.

Continue Reading »

Top